(Q40454541)

20 September 2017

1 reference

title

Dimensions of response to antidepressant agents in bulimia nervosa: a review. (English)

1 reference

20 September 2017

1 reference

Wolfe BE

1

1 reference

20 September 2017

publication date

1 June 1995

1 reference

Archives of Psychiatric Nursing

20 September 2017

published in

1 reference

20 September 2017

volume

9

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

111-121

1 reference

Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Treatment of bulimia with desipramine: a double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Alexithymia in the eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Psychopharmacology in the treatment of anorexia nervosa and bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Phenomenologic relationship of eating disorders to major affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Treating bulimia with desipramine. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Pharmacologic approaches in the treatment of eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Alexithymia ratings in bulimia nervosa: clinical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

A 3-year outcome study of normal-weight bulimia: assessment of psychosocial functioning and eating attitudes

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Affective disturbance in eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Bulimia treated with imipramine: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

A controlled study of alexithymia in eating disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Bulimia and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Phenelzine vs placebo in 50 patients with bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Long-term outcome of antidepressant treatment for bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

Assessment of social adjustment by patient self-report

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9417%2895%2980033-6

7 January 2021

10.1016/S0883-9417(95)80033-6

Identifiers

DOI

1 reference

20 September 2017

1 reference